| 标题 |
First-in-human phase I/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15Rα, as a single agent and in combination with spartalizumab in patients with advanced and metastatic solid tumors |
| 网址 | |
| DOI |
10.1136/jitc-2023-007725
doi
|
| 其它 |
期刊:Journal for ImmunoTherapy of Cancer 作者:Rom Leidner; Kevin Conlon; Douglas G McNeel; Andrea Wang-Gillam; Sumati Gupta; et al 出版日期:2023-10-01 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)